Drug-shortage tracker
National shortage status and effective dates for FDA-approved peptide products.
Not legal or medical advice.
This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.
| Product | Active ingredient | Shortage status | Resolved date | Source |
|---|---|---|---|---|
| Mounjaro / Zepbound | Tirzepatide | Resolved | 2024-12-19 | FDA declaratory order |
| Ozempic / Wegovy | Semaglutide | Resolved | 2025-02-21 | FDA declaratory order |
Sources
- Declaratory Order: Resolution of Shortages of Semaglutide Injection Products
U.S. Food and Drug Administration · Declaratory order · Drug Shortages
- Declaratory Order: Resolution of Shortages of Tirzepatide Injection Products
U.S. Food and Drug Administration · Declaratory order · Drug Shortages
Last updated: 2025-03-01
Next update: 2025-06-01